| Common Name | MVCD1,VEGF,VPF |
|---|---|
| Synonyms | rhuMAb-VEGF |
| Applications | ELISA |
| Recommended Dilutions | ELISA 1:5000-10000 |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Host Species | Humanized |
| IgG type | IgG1 |
| Reactivity | Human |
| Target | |
| Uniprot ID | P15692 |
| Description | Anti-VEGFA(bevacizumab biosimiar) mAb |
| Delivery | In Stock |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Usage | Research use only |
Anti-VEGFA(bevacizumab biosimiar) mAb
Price: 50μg $82.00 ; 100 μg $162.00
Product Data
Images
Figure 1. ELISA plate pre-coated by 1 μg/ml (100 μl/well) Human VEGFA , His tagged protein (PME100111) can bind Anti-VEGFA Neutralizing antibody (BME100061) in a linear range of 0.1-15 ng/ml.